Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high-or low-risk stigmata

Angel Lanas, Patricia Carrera-Lasfuentes, Luis A. García-Rodríguez, Santiago García, María Teresa Arroyo-Villarino, Julio Ponce, Luis Bujanda, José L. Calleja, Mónica Polo-Tomas, Xavier Calvet, Faust Feu, Angeles Perez-Aisa

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Abstract

© 2014 Informa Healthcare. Objective. To assess rates of further bleeding, surgery and mortality in patients hospitalized owing to peptic ulcer bleeding. Materials and methods. Consecutive patients hospitalized for peptic ulcer bleeding and treated with a proton pump inhibitor (PPI) (esomeprazole or pantoprazole) were identified retrospectively in 12 centers in Spain. Patients were included if they had high-risk stigmata (Forrest class Ia-IIb, underwent therapeutic endoscopy and received intravenous PPI ≥120 mg/day for ≥24 h) or low-risk stigmata (Forrest class IIc-III, underwent no therapeutic endoscopy and received intravenous or oral PPI [any dose]). Results. Of 935 identified patients, 58.3% had high-risk stigmata and 41.7% had low-risk stigmata. After endoscopy, 88.3% of high-risk patients and 22.1% of low-risk patients received intravenous PPI therapy at doses of at least 160 mg/day. Further bleeding within 72 h occurred in 9.4% and 2.1% of high- and low-risk patients, respectively (p < 0.001). Surgery to stop bleeding was required within 30 days in 3.5% and 0.8% of high- and low-risk patients, respectively (p = 0.007). Mortality at 30 days was similar in both groups (3.3% in high-risk and 2.3% in low-risk patients). Conclusion. Among patients hospitalized owing to peptic ulcer bleeding and treated with PPIs, patients with high-risk stigmata have a higher risk of further bleeding and surgery, but not of death, than those with low-risk stigmata.
Original languageEnglish
Pages (from-to)1181-1190
JournalScandinavian Journal of Gastroenterology
Volume49
DOIs
Publication statusPublished - 1 Jan 2014

Keywords

  • Peptic ulcer hemorrhage
  • Pharmacoepidemiology
  • Proton pump inhibitors
  • Retrospective study

Fingerprint Dive into the research topics of 'Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high-or low-risk stigmata'. Together they form a unique fingerprint.

Cite this